Hsin-yu Chen - Publications

COVID-19 mRNA vaccination and immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a target trial emulation study.

Journal: Journal for immunotherapy of cancer

Published: June 17, 2026

Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Journal: JCO oncology practice

Published: June 11, 2026

Cannabis use and cardiovascular, renal, and mortality outcomes in patients with type 2 diabetes receiving GLP-1 receptor agonists: A propensity score-matched cohort study.

Journal: Drug and alcohol dependence

Published: May 11, 2026

Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

Journal: JCO oncology practice

Published: May 06, 2026

Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

Journal: Diagnostics (Basel, Switzerland)

Published: May 02, 2026

Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 18, 2026

Correction: Chen et al. Deep Learning Applied to Defect Detection in Powder Spreading Process of Magnetic Material Additive Manufacturing. Materials 2022, 15, 5662.

Journal: Materials (Basel, Switzerland)

Published: April 15, 2026

Bispecific antibody AP402 targets p95HER2 and induces costimulation through CD137 to improve efficacy for HER2-positive tumors.

Journal: Molecular medicine (Cambridge, Mass.)

Published: March 22, 2026

SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis.

Journal: EClinicalMedicine

Published: February 17, 2026

Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation.

Journal: Diabetology & metabolic syndrome

Published: January 30, 2026

Comparative Effectiveness and Safety of Denosumab Versus Bisphosphonates in Elderly Patients with Cancer Bone Metastases: A Target Trial Emulation Study.

Journal: Life (Basel, Switzerland)

Published: January 25, 2026

Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes.

Journal: JCO oncology practice

Published: December 09, 2025